Current Size: 100%

Scientific Advisory Board

Regular evaluations and supervision by independent experts are an essential quality control component at LBI-RUD. The scientific advisory board (SAB) meets annually with LBI-RUD researchers to review and discuss the progress of the research program and the institute's performance. The board also provides expert advice on strategic questions concerning the research program, the academic career development of LBI-RUD team members, and the general organization of the institute, in order to reach and maintain the highest standards of research. The LBI-RUD SAB consists of five world-renowned experts in their fields:

FLTR:
Matthias Baumgartner
Children's Hospital Zurich & Rare Disease Initiative Zurich, University of Zurich, CH

Mirjam van der Burg
Erasmus MC, Rotterdam, NL

Cynthia Morton
Brigham And Women's Hospital, Harvard Medical School, Boston, US

William Gahl (Chair)
Head, NIH Undiagnosed Diseases Program & Clinical Director, NIH National Human Genome Research Institute, Bethesda, US

Barbara Prainsack
King's College, London, UK